Cargando…
DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27(Kip1) activity in neuroblastoma
Neuroblastoma (NB) is the most common extracranial pediatric tumor. NB patients over 18 months of age at the time of diagnosis are often in the later stages of the disease, present with widespread dissemination, and often possess MYCN tumor gene amplification. MYCN is a transcription factor that reg...
Autores principales: | KOOMOA, DANA-LYNN T., GEERTS, DIRK, LANGE, INGO, KOSTER, JAN, PEGG, ANTHONY E., FEITH, DAVID J., BACHMANN, ANDRÉ S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622674/ https://www.ncbi.nlm.nih.gov/pubmed/23440295 http://dx.doi.org/10.3892/ijo.2013.1835 |
Ejemplares similares
-
MycN promotes TRPM7 expression and cell migration in neuroblastoma through a process that involves polyamines
por: Lange, Ingo, et al.
Publicado: (2014) -
Use of Eflornithine (DFMO) in the Treatment of Early Alzheimer's Disease: A Compassionate Use, Single-Case Study
por: Alber, Jessica, et al.
Publicado: (2018) -
Difluoromethylornithine (DFMO) and Neuroblastoma: A Review
por: Tangella, Adarsh Vardhan, et al.
Publicado: (2023) -
Maintenance DFMO Increases Survival in High Risk Neuroblastoma
por: Sholler, Giselle L. Saulnier, et al.
Publicado: (2018) -
FTY-720 induces apoptosis in neuroblastoma via multiple signaling pathways
por: Lange, Ingo, et al.
Publicado: (2017)